Popular Articles

Provectus Completes Patient Accrual In Phase 2 Trial Of PV-10 For Metastatic Melanoma
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company has completed patient accrual and initial PV-10 treatment in its Phase 2 trial of PV-10 for metastatic melanoma. The study involved treatment of 80 subjects with Stage III or Stage IV metastatic melanoma.
generic viagra online
Mock CPR Drills In Kids Show Many Residents Fail In Key Skills, Hopkins Study Reveals
Research from the Johns Hopkins Children"s Center exposes alarming gaps in training hospital residents in "first response" emergency treatment of staged cardiorespiratory arrests in children, while at the same time offering a potent recipe for fixing the problem.
News of the day
Lilly Receives Fourth FDA Approval For ALIMTA(R) (pemetrexed For Injection)
Eli Lilly and Company (NYSE: LLY) announced it received a fourth approval from the U.S. Food and Drug Administration (FDA) for ALIMTA(R) (pemetrexed for injection). The latest approval is for ALIMTA as a maintenance therapy for locally advanced or metastatic non-small cell lung cancer (NSCLC), specifically for patients with a nonsquamous histology whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. ALIMTA is not indicated for treatment of patients with squamous cell non-small cell lung cancer.
Mental Health

California Medicaid Providers Win Legal Challenge

Medicaid providers in California won a legal challenge over program cuts in the case "Maxwell-Jolly v. Independent Living Center of Southern California." McKnight"s Long Term Care News reports that "The U.S. Supreme Court has let stand a federal appeals court ruling that says California"s Medicaid providers have a right to challenge state cuts to Medi-Cal provider fees. Victor Norma Jean Vescovo, the executive director of the Independent Living Center of Southern California, says the ruling will make it easier to ensure state Medicaid (known in the state as Medi-Cal) cuts will be made for needs-based reasons, not just economic reasons, the Bureau of National Affairs reported. "The Supreme Court"s decision to deny a review could set a precedent for providers across the country to challenge state cuts to Medicaid fees and services under the Medicaid Act. California currently is facing a major budget deficit of $24 billion for the fiscal year beginning July 1. Gov. Arnold Schwarzenegger (R) has proposed a series of drastic cuts to state services, including the state"s Medicaid program, which funds a major portion of nursing home costs" (6/24). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):